Human Regular 500 units/mL Insulin Therapy: A Review of Clinical Evidence and New Delivery Options.
作者信息
Sze David, Goldman Jennifer
机构信息
Becton Dickinson, Andover, MA.
MCPHS University, Boston, MA.
出版信息
Clin Diabetes. 2018 Oct;36(4):319-324. doi: 10.2337/cd18-0004.
Abstract
摘要
相似文献
1
Human Regular 500 units/mL Insulin Therapy: A Review of Clinical Evidence and New Delivery Options.人常规500单位/毫升胰岛素治疗：临床证据及新给药方式综述
Clin Diabetes. 2018 Oct;36(4):319-324. doi: 10.2337/cd18-0004.
2
Concentrated insulins in current clinical practice.目前临床实践中使用的浓缩胰岛素。
Diabetes Res Clin Pract. 2019 Feb;148:93-101. doi: 10.1016/j.diabres.2018.12.007. Epub 2018 Dec 21.
3
Absorption of subcutaneously administered regular human and porcine insulin in different concentrations.皮下注射不同浓度的常规人胰岛素和猪胰岛素的吸收情况。
Diabete Metab. 1985 Apr;11(2):106-10.
4
Insulin lispro: a review of its pharmacological properties and therapeutic use in the management of diabetes mellitus.赖脯胰岛素：其药理学特性及在糖尿病管理中的治疗应用综述
Drugs. 1997 Oct;54(4):597-614. doi: 10.2165/00003495-199754040-00006.
5
Cessation of insulin infusion at night-time during CSII-therapy: comparison of regular human insulin and insulin lispro.持续皮下胰岛素输注治疗期间夜间停止胰岛素输注：普通胰岛素与人胰岛素赖脯胰岛素的比较
Exp Clin Endocrinol Diabetes. 1998;106(3):168-72. doi: 10.1055/s-0029-1211971.
6
A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy.赖脯胰岛素与常规胰岛素用于妊娠期1型和2型糖尿病管理的比较。
J Matern Fetal Neonatal Med. 2008 May;21(5):309-13. doi: 10.1080/14767050802022797.
7
Changes to medication-use processes after overdose of U-500 regular insulin.U-500 常规胰岛素过量后用药流程的改变。
Am J Health Syst Pharm. 2012 Dec 1;69(23):2089-93. doi: 10.2146/ajhp110628.
8
Primary care diabetes. What options are there?基层医疗中的糖尿病。有哪些选择？
Aust Fam Physician. 2001 Dec;30(12):1122-8.
9
Effect of physicochemical variables of regular insulin formulations on their absorption from the subcutaneous tissue.常规胰岛素制剂的物理化学变量对其从皮下组织吸收的影响。
Diabetes Res Clin Pract. 1998 Apr;40(1):39-44. doi: 10.1016/s0168-8227(98)00021-7.
10
Insulin aspart: a review of its use in the management of type 1 or 2 diabetes mellitus.门冬胰岛素：1型或2型糖尿病管理中应用的综述
Drugs. 2004;64(17):1957-74. doi: 10.2165/00003495-200464170-00013.
引用本文的文献
1
Factors Affecting Performance of Insulin Pen Injector Technology: A Narrative Review.影响胰岛素笔注射技术性能的因素：叙事性综述。
J Diabetes Sci Technol. 2023 Mar;17(2):290-301. doi: 10.1177/19322968221145201. Epub 2022 Dec 20.
2
Treatment Patterns and Outcomes Before and After Humulin R U-500 Initiation Among US Patients with Type 2 Diabetes Previously Prescribed ≤ 200 Units/day of U-100 Insulin.美国之前每天胰岛素用量≤200单位U-100的2型糖尿病患者起始使用优泌林R U-500前后的治疗模式及结局
Diabetes Ther. 2022 Mar;13(3):465-479. doi: 10.1007/s13300-022-01209-z. Epub 2022 Feb 21.
3
Pharmacokinetics and Pharmacodynamics of Human Regular U-500 Insulin Administered via Continuous Subcutaneous Insulin Infusion Versus Subcutaneous Injection in Adults With Type 2 Diabetes and High-Dose Insulin Requirements.U-500 人胰岛素在成人 2 型糖尿病和高剂量胰岛素需求患者中的药代动力学和药效学：连续皮下胰岛素输注与皮下注射比较。
J Diabetes Sci Technol. 2022 Mar;16(2):401-407. doi: 10.1177/1932296820972719. Epub 2020 Nov 26.
本文引用的文献
1
The impact of extended release exenatide as adjuvant therapy on hemoglobin A1C, weight, and total daily dose of insulin in patients with type 2 diabetes mellitus using U-500 insulin.使用 U-500 胰岛素的 2 型糖尿病患者中，长效艾塞那肽作为辅助治疗对糖化血红蛋白、体重和胰岛素日总剂量的影响。
Diabetes Res Clin Pract. 2017 Dec;134:38-43. doi: 10.1016/j.diabres.2017.09.008. Epub 2017 Sep 23.
2
Clinical Experience with U-500 Regular Insulin by Multiple Daily Injections and Continuous Subcutaneous Insulin Infusion.多次皮下注射和持续皮下胰岛素输注使用U-500常规胰岛素的临床经验
Diabetes Technol Ther. 2017 Apr;19(4):220-225. doi: 10.1089/dia.2016.0411. Epub 2017 Mar 1.
3
Patient-reported outcomes in transition from high-dose U-100 insulin to human regular U-500 insulin in severely insulin-resistant patients with type 2 diabetes: analysis of a randomized clinical trial.2型糖尿病严重胰岛素抵抗患者从高剂量U-100胰岛素转换为普通U-500人胰岛素时的患者报告结局：一项随机临床试验的分析
Health Qual Life Outcomes. 2016 Sep 30;14(1):139. doi: 10.1186/s12955-016-0541-4.
4
New Insulin Delivery Recommendations.新胰岛素输送推荐意见。
Mayo Clin Proc. 2016 Sep;91(9):1231-55. doi: 10.1016/j.mayocp.2016.06.010.
5
Insulin Injection Into Lipohypertrophic Tissue: Blunted and More Variable Insulin Absorption and Action and Impaired Postprandial Glucose Control.胰岛素注射至脂肪肥厚组织：胰岛素吸收和作用减弱且变异性更大，以及餐后血糖控制受损。
Diabetes Care. 2016 Sep;39(9):1486-92. doi: 10.2337/dc16-0610. Epub 2016 Jul 13.
6
Pen Device for U-500 Insulin; Tamper-Resistant Seals; Dispelling Myths About ISMP.U-500胰岛素笔式装置；防篡改密封；消除关于ISMP的误解。
Hosp Pharm. 2016 Apr;51(4):279-83. doi: 10.1310/hpj5104-279.
7
Management of U-500 insulin users during inpatient admissions within a Veterans Affairs Medical Center.退伍军人事务医疗中心住院期间U-500胰岛素使用者的管理
Diabetes Res Clin Pract. 2016 Apr;114:32-6. doi: 10.1016/j.diabres.2016.02.004. Epub 2016 Feb 16.
8
Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial.胰岛素泵治疗与多次皮下注射治疗2型糖尿病的持续疗效对比：来自OpT2mise随机试验的12个月数据
Diabetes Obes Metab. 2016 May;18(5):500-7. doi: 10.1111/dom.12642. Epub 2016 Mar 22.
9
EFFECT OF TOTAL DAILY DOSE ON EFFICACY, DOSING, AND SAFETY OF 2 DOSE TITRATION REGIMENS OF HUMAN REGULAR U500 INSULIN IN SEVERELY INSULIN-RESISTANT PATIENTS WITH TYPE 2 DIABETES.每日总剂量对严重胰岛素抵抗的2型糖尿病患者使用人常规U500胰岛素两种剂量滴定方案的疗效、给药及安全性的影响
Endocr Pract. 2016 Jun;22(6):653-65. doi: 10.4158/EP15959.OR. Epub 2016 Jan 20.
10
As U-500 Insulin Safety Concerns Mount, It's Time to Rethink Safe Use of Strengths Above U-100.随着U-500胰岛素安全问题日益突出，是时候重新思考高于U-100强度胰岛素的安全使用问题了。
Home Healthc Now. 2015 Oct;33(9):501-2. doi: 10.1097/NHH.0000000000000292.
Zotero 插件